Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

• Last SEC data release: 2025-02-14
• Last 15 days FTD volume: €0.01 M
• Last 3 months FTD volume: €0.28 M
• Last year FTD volume: €0.28 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
GlaxoSmithKline GSK	€81.01 M	€0.17 B	🇬🇧 UK
Sanofi SNY	€1.21 M	€47.51 M	🇫🇷 France
Biogen BIIB	€42.57 M	€88.22 M	🇺🇸 USA
AstraZeneca AZN	€38.6 M	€0.18 B	🇬🇧 UK
Alnylam Pharmaceuticals ALNY	€10.14 M	€36.36 M	🇺🇸 USA
Sangamo Therapeutics SGMO	€2.1 M	€6.39 M	🇺🇸 USA
Bristol-Myers Squibb BMY	€0.16 B	€0.47 B	🇺🇸 USA